Epigenetic silencing of the ubiquitin ligase subunit FBXL7 impairs c-SRC degradation and promotes epithelial-to-mesenchymal transition and metastasis
- 24 August 2020
- journal article
- research article
- Published by Springer Nature in Nature Cell Biology
- Vol. 22 (9) , 1130-1142
Abstract
Epigenetic plasticity is a pivotal factor that drives metastasis. Here, we show that the promoter of the gene that encodes the ubiquitin ligase subunit FBXL7 is hypermethylated in advanced prostate and pancreatic cancers, correlating with decreased FBXL7 mRNA and protein levels. Low FBXL7 mRNA levels are predictive of poor survival in patients with pancreatic and prostatic cancers. FBXL7 mediates the ubiquitylation and proteasomal degradation of active c-SRC after its phosphorylation at Ser 104. The DNA-demethylating agent decitabine recovers FBXL7 expression and limits epithelial-to-mesenchymal transition and cell invasion in a c-SRC-dependent manner. In vivo, FBXL7-depleted cancer cells form tumours with a high metastatic burden. Silencing of c-SRC or treatment with the c-SRC inhibitor dasatinib together with FBXL7 depletion prevents metastases. Furthermore, decitabine reduces metastases derived from prostate and pancreatic cancer cells in a FBXL7-dependent manner. Collectively, this research implicates FBXL7 as a metastasis-suppressor gene and suggests therapeutic strategies to counteract metastatic dissemination of pancreatic and prostatic cancer cells.Keywords
Funding Information
- U.S. Department of Health & Human Services | National Institutes of Health (CA168611, CA215471, CA206105, CA76584)
- the Pancreatic Cancer Action Network Translational Research Grant
This publication has 57 references indexed in Scilit:
- Amplified Genes May Be Overexpressed, Unchanged, or Downregulated in Cervical Cancer Cell LinesPLOS ONE, 2012
- Novel E3 ligase component FBXL7 ubiquitinates and degrades Aurora A, causing mitotic arrestCell Cycle, 2012
- FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomasNature, 2012
- Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progressionInternational Journal of Cancer, 2011
- An Integrated Phosphoproteomics Work Flow Reveals Extensive Network Regulation in Early Lysophosphatidic Acid SignalingMolecular & Cellular Proteomics, 2010
- Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasisProceedings of the National Academy of Sciences, 2010
- Src signaling in cancer invasionJournal of Cellular Physiology, 2010
- Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival SignalsCancer Cell, 2009
- EMT: When epithelial cells decide to become mesenchymal-like cellsJournal of Clinical Investigation, 2009
- Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferationBlood, 2008